139 related articles for article (PubMed ID: 10841787)
1. Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity.
Masters JJ; Franciskovich JB; Tinsley JM; Campbell C; Campbell JB; Craft TJ; Froelich LL; Gifford-Moore DS; Hay LA; Herron DK; Klimkowski VJ; Kurz KD; Metz JT; Ratz AM; Shuman RT; Smith GF; Smith T; Towner RD; Wiley MR; Wilson A; Yee YK
J Med Chem; 2000 Jun; 43(11):2087-92. PubMed ID: 10841787
[No Abstract] [Full Text] [Related]
2. Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.
Wiley MR; Weir LC; Briggs S; Bryan NA; Buben J; Campbell C; Chirgadze NY; Conrad RC; Craft TJ; Ficorilli JV; Franciskovich JB; Froelich LL; Gifford-Moore DS; Goodson T; Herron DK; Klimkowski VJ; Kurz KD; Kyle JA; Masters JJ; Ratz AM; Milot G; Shuman RT; Smith T; Smith GF; Tebbe AL; Tinsley JM
J Med Chem; 2000 Mar; 43(5):883-99. PubMed ID: 10715155
[TBL] [Abstract][Full Text] [Related]
3. Discovery of transition state factor Xa inhibitors as potential anticoagulant agents.
Zhu BY; Huang W; Su T; Marlowe C; Sinha U; Hollenbach S; Scarborough RM
Curr Top Med Chem; 2001 Jun; 1(2):101-19. PubMed ID: 11899247
[TBL] [Abstract][Full Text] [Related]
4. New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.
Amin KM; Abdel Gawad NM; Abdel Rahman DE; El Ashry MK
Bioorg Chem; 2014 Feb; 52():31-43. PubMed ID: 24316885
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-[2-hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (darexaban, YM150) as a potent and orally available factor Xa inhibitor.
Hirayama F; Koshio H; Ishihara T; Hachiya S; Sugasawa K; Koga Y; Seki N; Shiraki R; Shigenaga T; Iwatsuki Y; Moritani Y; Mori K; Kadokura T; Kawasaki T; Matsumoto Y; Sakamoto S; Tsukamoto S
J Med Chem; 2011 Dec; 54(23):8051-65. PubMed ID: 21995444
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant and Antithrombotic Properties of Three Structurally Correlated Sea Urchin Sulfated Glycans and Their Low-Molecular-Weight Derivatives.
Vasconcelos AA; Sucupira ID; Guedes AL; Queiroz IN; Frattani FS; Fonseca RJ; Pomin VH
Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30200211
[TBL] [Abstract][Full Text] [Related]
7. Investigation of factor Xa inhibitors containing non-amidine S1 elements.
Franciskovich JB; Masters JJ; Tinsley JM; Craft TJ; Froelich LL; Gifford-Moore DS; Klimkowski VJ; Smallwood JK; Smith GF; Smith T; Towner RR; Weir LC; Wiley MR
Bioorg Med Chem Lett; 2005 Nov; 15(21):4838-41. PubMed ID: 16140530
[TBL] [Abstract][Full Text] [Related]
8. Factor Xa is a superior target to factor IIa for antithrombotic therapies.
Büller HR
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():37. PubMed ID: 14730477
[No Abstract] [Full Text] [Related]
9. Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.
Yang J; Su G; Ren Y; Chen Y
Eur J Med Chem; 2015 Aug; 101():41-51. PubMed ID: 26114810
[TBL] [Abstract][Full Text] [Related]
10. Factor Xa inhibitors: today and beyond.
Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationship of oxazolidinone derivatives containing novel S4 ligand as FXa inhibitors.
Zhao Y; Jiang M; Zhou S; Wu S; Zhang X; Ma L; Zhang K; Gong P
Eur J Med Chem; 2015; 96():369-80. PubMed ID: 25911624
[TBL] [Abstract][Full Text] [Related]
12. N(2)-Aroylanthranilamide inhibitors of human factor Xa.
Yee YK; Tebbe AL; Linebarger JH; Beight DW; Craft TJ; Gifford-Moore D; Goodson T; Herron DK; Klimkowski VJ; Kyle JA; Sawyer JS; Smith GF; Tinsley JM; Towner RD; Weir L; Wiley MR
J Med Chem; 2000 Mar; 43(5):873-82. PubMed ID: 10715154
[TBL] [Abstract][Full Text] [Related]
13. Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.
Lee YK; Player MR
Med Res Rev; 2011 Mar; 31(2):202-83. PubMed ID: 19967784
[TBL] [Abstract][Full Text] [Related]
14. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.
Chackalamannil S
J Med Chem; 2006 Sep; 49(18):5389-403. PubMed ID: 16942011
[No Abstract] [Full Text] [Related]
15. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ
Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
[TBL] [Abstract][Full Text] [Related]
17. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
18. Identification of potent orally active factor Xa inhibitors based on conjugation strategy and application of predictable fragment recommender system.
Ishihara T; Koga Y; Iwatsuki Y; Hirayama F
Bioorg Med Chem; 2015 Jan; 23(2):277-89. PubMed ID: 25523211
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa inhibitors: next-generation antithrombotic agents.
Pinto DJ; Smallheer JM; Cheney DL; Knabb RM; Wexler RR
J Med Chem; 2010 Sep; 53(17):6243-74. PubMed ID: 20503967
[No Abstract] [Full Text] [Related]
20. Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties.
Pinto DJ; Galemmo RA; Quan ML; Orwat MJ; Clark C; Li R; Wells B; Woerner F; Alexander RS; Rossi KA; Smallwood A; Wong PC; Luettgen JM; Rendina AR; Knabb RM; He K; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2006 Nov; 16(21):5584-9. PubMed ID: 16963264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
